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8366 | RSC Adv., 2017, 7, 8366–8375e biomaterials from self-assembly
in polysaccharide and peptide amphiphile mixtures:
controllable structural and mechanical properties
and antimicrobial activity†
V. Castelletto,a A. Kaur,a I. W. Hamley,*a R. H. Barnes,a K.-A. Karatzas,a D. Hermida-
Merino,b S. Swioklo,c C. J. Connon,c J. Stasiak,d M. Rezae and J. Ruokolainene
Macroscopic capsules, with tunable properties based on hierarchical self-assembly on multiple
lengthscales, are prepared from the co-operative self-assembly of polysaccharide and peptide
amphiphiles. Diﬀerent formulations can be used to create ﬂexible membrane sacs in solution, soft
capsules or rigid free-standing capsules. Samples are prepared by injecting a solution containing sodium
alginate, with or without graphene oxide (GO), into a matrix consisting of a solution containing the
peptide amphiphile PA C16-KKFF (K: lysine, F: phenylalanine), with or without CaCl2. Graphene oxide is
added to the hybrid materials to modulate the mechanical properties of the capsules. Injection of
sodium alginate solution into a pure PA matrix provides a ﬂexible membrane sac in solution, while
injection of NaAlg/GO solution into a PA matrix gives a soft capsule. Alternatively, a rigid free-standing
capsule is made by injecting a NaAlg/GO solution into a PA + CaCl2 matrix solution. A comprehensive
insight into the hierarchical order within the capsules is provided through analysis of X-ray scattering
data. A novel “Langmuir–Blodgett” mechanism is proposed to account for the formation of the sacs and
capsules as the alginate solution is injected at the interface of the PA solution. The capsules show
a unique antibacterial eﬀect speciﬁc for the Gram positive bacterium Listeria monocytogenes, which is
an important human pathogen. The hybrid nanostructured capsules thus have remarkable bioactivity and
due to their tunable structural and functional properties are likely to have a diversity of other future
applications.1. Introduction
Peptide amphiphiles (PAs) are a class of remarkable self-
assembling molecules that incorporate the diverse function-
ality of amino acid residues. An important class of PA is that of
lipopeptides in which a hydrophilic peptide sequence is
attached to one or more lipid chains. Such molecules are
produced in living systems1 (for example as part of the bacterialod Biosciences, University of Reading,
l: I.W.Hamley@reading.ac.uk
ESRF, 71 avenue des Martyrs, 38000
niversity, International Centre for Life,
3BZ, UK
otechnology, Pembroke Street, Cambridge
sity School of Science, P.O. Box 15100, FI-
(ESI) available: SAXS data tting
image of membrane sac, SEM images,
s, rheology and texture analysis data.host defense system) and are designed and synthesized by
researchers interested in their self-assembly properties and
biological activity.1–11 In many examples, it has been demon-
strated that PAs have enhanced stability and bioactivity
compared to the constituent peptide7,12–16 because self-assembly
into brillar structures presents the functional peptide motif at
high density, and because the lipid confers compatibility with
biological membranes.
The possibility to prepare novel hybrid materials by
combining these properties of PAs and peptides with those of
biopolymers leads to the potential to produce novel hybrid
biomaterials with remarkable and unique structural and func-
tional properties. Hybrid systems examined in early pioneering
studies include PAs with polysaccharides,17–20 PAs with
recombinant structural proteins,21 and amyloid peptides22 or
polysaccharides such as sodium alginate (NaAlg)23–26 with gra-
phene oxide (GO). Introduction of GO is of interest in the
development of hybrid materials with enhanced electrical
conductivity, mechanical and/or barrier properties23–26 among
others. In a pioneering study, membrane sac formation was
observed at the interface of aqueous solutions of highmolecularThis journal is © The Royal Society of Chemistry 2017
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View Article Onlineweight polysaccharide (hyaluronic acid) and a cationic designer
PA.17 It was proposed that the membrane structure results from
the formation of a PA bril network diﬀusion barrier, leading to
polysaccharide nanobril bundle growth perpendicular to the
interface.17 Stem cell growth and slow release of encapsulated
proteins is supported by sacs enclosing PA gel. In subsequent
work, the mechanical properties and membrane permeability
were examined in more detail.18 Membranes formed by PAs
bearing the KLAKLAK peptide (which has anti-cancer activity)
mixed with hyaluronic acid were also fabricated and their
cytotoxicity towards breast cancer cells was examined.19 A
change in PA aggregate structure from cylindrical brils to
spheres was also noted for this system.19 Membranes formed by
complexation of a PA bearing a heparin-binding sequence and
several polysaccharides have been prepared and their structure
has been probed by SAXS and electron microscopy.20 Remark-
ably, in some cases, evidence for cubic phase structure within
the membrane instead of lamellar of hexagonal ordering was
observed.20 Mata and coworkers have recently shown that
complexation of cationic PAs with elastin-like proteins
produces robust membranes with remarkable mechanical
properties such as exemplied by the ability to draw out tubes
from membranes, and to extend tubules from the tube walls.21
These materials could be used to create substrates for stem cell
growth, showing their great potential in tissue engineering
applications.21
We have previously investigated the self-assembly of the PA
C16-KKFF (C16: palmitoyl chain, K: lysine, F: phenylalanine) in
water and showed that it forms small (5–6 nm diameter)
spherical micelles.27 This PA was studied as part of a work on
the enzymatic degradation of C16-KKFFVLK (L: leucine, V:
valine)27 which itself self-assembles into helically twisted
ribbons and nanotubes at suﬃciently high concentration.28 The
peptide sequence in C16-KKFFVLK is based on a core aggre-
gating sequence from the amyloid b (Ab) peptide,29 KLVFF, the
self-assembly of which we previously examined.30 In C16-
KKFFVLK, the KLVFF sequence is attached right-to-le from the
C terminus with an additional KKF sequence. As a result, KK
and FF sequences are expected to improve the water solubility
and promote b-sheet formation through aromatic stacking (p–
p) interactions31 respectively, for both C16-KKFFVLK and C16-
KKFF PAs.
Here we investigate the formation of macroscopic objects
including membrane sacs and so or rigid capsules. These
objects are self-assembled by injecting NaAlg sol with or without
GO into a matrix consisting of a C16-KKFF solution with or
without CaCl2. We examine the structural and mechanical
properties of the sac and capsules using several scattering,
microscopy and rheology instruments. In addition, we perform
biological assays to examine the cytocompatibility and antimi-
crobial activity of the membrane sac.
We nd evidence for unique hierarchical ordering in these
novel self-assembled macroscopic objects and a signicant
inuence of GO and CaCl2 on their mechanical properties. In
particular, membrane sacs have excellent intrinsic antimicro-
bial properties against Listeria monocytogenes and other Gram
positive bacteria.This journal is © The Royal Society of Chemistry 20172. Experimental
Materials
Peptide amphiphiles C16-KKFF and C16-G3RGD were synthe-
sized by CS Bio (USA) and supplied as a TFA salts. Themolecular
weight was found to be 807.31 Da (expected 807.11 Da) and
755.47 Da (expected 755.91 Da) for C16-KKFF and C16-G3RGD
respectively, as revealed by electrospray ionization mass spec-
trometry. Purity of the samples was 99.88% and 98.4%, for C16-
KKFF and C16-G3RGD respectively, by analytical HPLC in a 0.1%
TFA water/acetonitrile gradient.
Sodium alginate (NaAlg) and graphene oxide (GO) were
purchased from Sigma Aldrich (UK). The molecular weight of
NaAlg was determined to be very polydisperse, in the range
12 000–40 000 g mol1, according to viscosity experiments. GO
was bought as a 4 mg ml1 dispersion in water.
GO has a negative electrostatic charge within the pH range 2–
7.32 C16-KKFF and C16-G3RGD are positively charged for pH 1–3
(+2 and +1 for C16-KKFF and C16-G3RGD respectively),33 while
NaAlg is negatively charged at pH 5–7. This was empirically
conrmed by the measured z-potential and pH values of the
solutions listed in Table 1. Solutions containing only PA were
mixed using an ultrasound bath for 20 minutes. Pure NaAlg and
GO/NaAlg solutions were mixed by alternating ultrasound bath
and vortex mixing for 20 minutes. All solutions were allowed to
equilibrate for at least three hours prior to use.Zeta potential measurements
The zeta potential was measured using a Zetasizer Nano 2s from
Malvern Instruments. An aliquot 1 ml of sample was placed
inside a disposable folded capillary cell. The sample was le to
equilibrate for 120 s before measuring the zeta potential, using
an applied voltage of 50.0 V. The results presented are the
average over three measurements. The zeta potential of 2 wt%
NaAlg with 0.34% GO (Table 1) was not measured due to the
dark colour of the sample.Scanning electron microscopy (SEM)
Aer sac/capsule production, the excess peptide solution was
exchanged by water. The water was subsequently exchanged by
a xative solution containing 3% paraformaldehyde, 1.5%
glutaraldehyde and 2.5% sucrose. This was followed by gradual
dehydration from 10 to 100% ethanol (10, 30, 50, 70, 90, 100%
ethanol), waiting 30 seconds between dehydration steps. The
sample was then extracted from the 100% ethanol solution and
subjected to critical point drying. An incision was made in the
dried sac/capsule, to allow for observation of internal and external
surfaces. The dried sample was placed on a stub covered with
a carbon tab (Agar Scientic, UK), and then coated with gold. A
FEI Quanta FEG 600 environmental scanning electronmicroscope
(SEM) was used to study and record SEM images of the dried sacs.Laser scanning confocal microscopy (LSCM)
Experiments were performed on a Leica TCS SP2 confocal
systemmounted on a Leica DM-IRE2 upright microscope, usingRSC Adv., 2017, 7, 8366–8375 | 8367
Table 1 NaAlg solutions mixed (M) or injected (I) in PA solution, to produce sol I, sol II, the membrane sac, cap I and cap IIa
PA solution
Alginate solution
0.03 wt% NaAlg (M),
pH 6.22,
z ¼ 77.6  4.7 mV
0.2 wt% NaAlg (I),
pH 6.72,
z ¼ 65.1  5.0 mV
2 wt% NaAlg (I),
pH 6.16,
z ¼ 118  6.9 mV
2 wt% NaAlg/0.02%
GO (I), pH 5.48,
z ¼ 89.7  6.2 mV
2 wt% NaAlg/0.34%
GO (I), pH 4.41
1 wt% C16-KKFF Sol I Sol II
pH 2.45
z ¼ 32.7  2.2 mV
2 wt% C16-KKFF Membrane sac
pH 2.51
z ¼ 37.3  2.9 mV
5 wt% C16-KKFF Cap I
pH 2.23
z ¼ 28.4  1.3 mV
2 wt% C16-KKFF
(0.144 wt% CaCl2)
Cap II
pH 2.77
z ¼ 27.3  1.9 mV
a Sample conditions. M: mixed, I: injected.
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View Article Onlinean objective 20 with 0.4 NA numerical aperture. Aer 12 h
membrane sac production, the peptide solution excess was
removed and replaced by water. The water was then replaced by
a solution containing 3  104 wt% rhodamine B (RhoB) uo-
rescent dye. The sample was le to rest for 90 minutes before
LSCM examination. The excitation wavelength generated by an
argon laser was 514 nm, while the emission detection was in the
range 558–617 nm. Samples were put between a glass slide and
a coverslip.Cryogenic transmission electron microscopy (cryo-TEM)
Experiments were carried out using a eld emission cryo-
electron microscope (JEOL JEM-3200FSC) operating at 300 kV.
Images were taken using bright-eld mode and zero loss energy
ltering (omega type) with a slit with 20 eV. Micrographs were
recorded using a Gatan Ultrascan 4000 CCD camera. The
specimen temperature was maintained at 187 C during the
imaging. Vitried specimens were prepared using an auto-
mated FEI Vitrobot device using Quantifoil 3.5/1 holey carbon
copper grids with 3.5 mm hole sizes. Grids were cleaned using
a Gatan Solarus 9500 plasma cleaner just prior to use and then
transferred into an environmental chamber of FEI Vitrobot at
room temperature and 100% humidity. Thereaer, 3 ml of
sample solution was applied on the grid, blotted once for 1
second and then vitried in a 1/1 mixture of liquid ethane and
propane at 180 C. Grids with vitried sample solutions were
maintained in a liquid nitrogen atmosphere and then cryo-
transferred into the microscope.X-ray diﬀraction (XRD)
XRD was performed on a peptide stalk prepared by drying
a sample between the ends of wax-coated capillaries, resulting8368 | RSC Adv., 2017, 7, 8366–8375in a stalk le on the end of one capillary. The sample was
mounted (vertically) onto the goniometer of an Oxford Instru-
ments Gemini X-ray diﬀractometer, equipped with a Sapphire 3
CCD detector. The sample to detector distance was 45 mm.
CrystalClear soware was used to reduce the 2D-data to a one-
dimensional intensity prole.
Small angle X-ray scattering (SAXS)
Synchrotron SAXS experiments on solutions were performed on
beamline B21 at Diamond (Didcot, UK) and on beamline BM29
at the ESRF (Grenoble, France), using a BioSAXS robot.
Synchrotron SAXS experiments on the membrane sac and
capsules were performed on beamline BM26B (DUBBLE) at the
ESRF.
At B21 and BM29, solutions were loaded into the 96 well
plate of an EMBL BioSAXS robot, and then injected via an
automated sample exchanger into a quartz capillary (1.8 mm
internal diameter) in the X-ray beam. The quartz capillary was
enclosed in a vacuum chamber, in order to avoid parasitic
scattering. Aer the sample was injected in the capillary and
reached the X-ray beam, the ow was stopped during the SAXS
data acquisition. B21 operated with a xed camera length (3.9
m) and xed energy (12.4 keV) while BM29 operated with l ¼
1.03 A˚ (12 keV). The images were captured using a PILATUS 2M
and 1M detector at B21 and BM29 respectively. Data processing
was performed using dedicated beamline soware Scatter (B21)
or ISPYB (BM29).
On BM26B, capsules or membrane sacs were placed in DSC
pans modied withmica windows to enable transmission of the
X-ray beam. The sample to SAXS detector distance was 3.16 m
using a wavelength of 1.033 A˚. A Dectris-Pilatus 1M detector
with a resolution of 981  1043 pixels and a pixel size of 172 
172 mm was used to acquire the 2D SAXS scattering patterns.This journal is © The Royal Society of Chemistry 2017
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View Article OnlineStandard corrections for sample absorption and background
subtraction were performed. The data were normalized to the
intensity of the incident beam (in order to correct for primary
beam intensity uctuations) and were corrected for absorption,
background scattering. Diﬀraction from silver behenate was
used to calibrate the wavevector scale of the scattering curve.
Texture analysis
Experiments were performed using a XT-Plus Texture Analyser
from Stable Micro Systems. One capsule, placed on the surface
of a 5 kg load cell, was compressed against the cell surface using
a circular at tip tool of 4 mm diameter. The tool compressed
the sample at a 0.1 mm s1 speed. Compression started aer the
tool measured a 0.1 g resistant force from the sample.
Rheology
Rheological properties were determined using a controlled
stress TA Instruments AR-2000 rheometer (TA Instruments).
The experiments were performed using a cone-and-plate
geometry (cone radius ¼ 20 cm; cone angle ¼ 1). The surface
to be compressed by the cone was coated with membrane sacs
or capsules. The linear regime was rst determined performing
oscillatory stress experiments at a constant angular frequency of
6.28 rad s1. Frequency sweep experiments were performed
a constant oscillatory stress within the linear regime, and
angular frequencies between between 0.1 and 627 rad s1.
Examination of cytocompatibility
Human adipose-derived stem cells (hASCs) obtained from the
subcutaneous fat of healthy donors (Invitrogen, UK), were used
for biocompatibility experiments. Following recovery from cry-
ostorage, cells were seeded at 800 cells per cm2 and maintained
in reduced-serum (RS) growth medium [MesenPRO™ RS
medium containing 2 mMGlutaMAX™ and 1% (v/v) antibiotic–
antimycotic (all from Life Technologies, UK)] in a humidied
incubator at 37 C and 5% CO2 with medium changes every 3–4
days until approximately 80% conuence was reached. Cells
were harvested using TrypLE™ Express enzyme (Life Technol-
ogies, UK) and seeded at a density of 20 000 cells per cm2 in
ultra-low attachment plates (Corning, UK) containing lms on
glass coverslips coated with dried membrane sacs or so
capsules. hASCs were seeded onto tissue culture plastic,
calcium alginate lms, and sodium alginate lms using the
same methodology. Cells were maintained in growth medium
for 24 hours before washing with PBS and staining cells with 1
mM calcein-AM (eBioscience, UK) and 2 mM ethidium
homodimer-1 (Sigma Aldrich, UK) for 15 minutes at 37 C. Live
and dead cells were then examined using an Axiovert 200M
inverted microscope (Zeiss, UK).
Bacterial strains and growth conditions
Experiments were performed in ve diﬀerent microorganisms
namely, Staphylococcus aureus, Listeria monocytogenes, Entero-
coccus faecalis, Pseudomonas aeruginosa and Escherichia coli. The
strains used were as follows: a wild type Staphylococcus aureusThis journal is © The Royal Society of Chemistry 2017previously isolated from ham and used in experiments,34 L.
monocytogenes LO28 that has also widely been used in various
publications35,36 E. coli K-12 is one of the most widely used
strains of this bacterium, E. faecalis NCTC 775 has been utilised
in previous antimicrobial experiments and P. aeruginosa NCTC
10299 was isolated from human faeces. Stock cultures were
stored at 80 C in 7% (vol/vol) DMSO (Sigma-Aldrich, Dorset,
UK). Prior to experiments, stock cultures of S. aureus, L. mono-
cytogenes E. faecalis and P. aeruginosa were streaked onto brain
heart infusion (BHI) agar (LAB M, Lancashire, UK) while those
of E. coli were streaked onto Lysogeny Broth (LB) agar (Oxoid,
UK) and incubated overnight at 37 C. Three colonies from
these cultures were then transferred to 3 ml sterile broth. BHI
broth (LAB M, Lancashire, UK) was used for L. monocytogenes, S.
aureus, E. faecalis and P. aeruginosa while LB broth (LAB M,
Lancashire, UK) was used for E. coli at 37 C under agitation for
24 hours (overnight). Subsequently, 100 ml of these overnight
cultures was used for the microbial peptide challenge.Microbial peptide challenge
Prior to experiments, the initial cell concentration of the
overnight cultures was estimated via sampling and prepara-
tion of decimal dilutions in maximum recovery diluent (MRD;
Oxoid, Hampshire, UK). More specically, MRD used for S.
aureus alone was supplemented with 5% Tween 80 (ICI
Surfactants, Wilmington, DE) to alleviate the clumping of
cells, as shown previously.34 Subsequently, 10 ml of each dilu-
tion were plated onto BHI agar (LAB M, Lancashire, UK) for L.
monocytogenes and S. aureus or LB agar (Oxoid, UK) for E. coli.
All samples were plated in duplicate and plates were incubated
at 37 C for 24 hours. Subsequently, colonies were counted to
assess the bacterial count of each target organism in the initial
cultures.
Thermo Scientic Nunc MicroWell 96-Well round-bottomed
Microplates (Thermo scientic, Denmark) were used for the
microbial peptide challenge experiments. Wells were treated by
coating with either a 2 wt% NaAlg solution or a membrane sac,
and allowed to dry for 24 hours. Following the treatment of the
wells, 100 ml of the same overnight culture from each of the
microorganisms was placed in equal numbers of wells coated
with membrane sacs or NaAlg solution (control). Subsequently,
plates were placed in a fume hood for 5 days or outside the fume
hood and wrapped in plastic to prevent any evaporation of the
medium present in the culture. This was done to assess the
antimicrobial activity under possible applications on a dry
surface or in a liquid medium. It was noticed that in the fume
hood the 100 ml of all culture samples were evaporated
completely within 24 h. Following the placement of the cultures
in the wells, samples were taken to assess cell viability every 24 h
for a period of 5 days (dried wells) or 2 days (liquid in wells).
Specically, samples from the dry wells in plates placed in the
fume hood, were taken by the addition of 200 ml of sterile MRD
in each well and using the pipette to mix 20 times to resuspend
the cells. Subsequently, samples were serially diluted in decimal
dilutions and plated onto the corresponding solid media, as
described above. It should be mentioned that the rst dilutionRSC Adv., 2017, 7, 8366–8375 | 8369
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View Article Onlinewas prepared by transferring the 200 ml from the well into 800 ml
of MRD while all other dilutions were prepared by using 100 ml
of the previous dilution into 900 ml of fresh MRD. Following
incubation of the plates at 37 C for 24 h, colony counts were
taken to assess viability. All measurements of the viable counts
at each time points were performed in triplicate.3. Results
We rst investigated the inuence of the mixing procedure on
the self-assembly in mixtures of the PA C16-KKFF bearing two
cationic lysine residues and NaAlg, the Alg bearing a negative
charge. A profound and unexpected diﬀerence in morphology
was observed comparing a sample made by dissolving PA
powder into a NaAlg solution (sol I, Table 1) to one prepared by
injecting NaAlg solution into PA solution (sol II). Stupp's group
used the latter technique to prepare sacs in hybrid
polysaccharide/PA mixtures.17 The concentrations of the PA and
NaAlg are listed in Table 1. Fig. 1 presents images from cryo-
TEM along with SAXS data, highlighting the completely
distinct self-assembled nanostructures. The cryo-TEM image for
sol I shows spherical micelles coexisting with micellar clusters.
The spherical micelle structure is very similar to that for C16-
KKFF previously reported,27 as conrmed by SAXS (to be dis-
cussed shortly). However, micelle clusters were not observed for
a pure C16-KKFF solution27 and the clusters observable in Fig. 1b
are therefore ascribed to attractive interactions between C16-
KKFF and the NaAlg. In complete contrast to the morphologyFig. 1 Transition frommicelles to nanosheets upon injection of sodium a
micelles (examples highlighted with white arrows) and micelle clusters (
SAXS from sol II.
8370 | RSC Adv., 2017, 7, 8366–8375shown in Fig. 1a and b, the presence of planar membranes is
evident in the cryo-TEM images shown in Fig. 1c for sol II.
The SAXS data for sol II shown in Fig. 1c provides further
insight including quantitative information on nanostructure
dimensions. In particular, there is a weak Bragg peak in the
data, corresponding to a period d ¼ 42.8 A˚ (Fig. 1c). This weak
Bragg peak is ascribed to the formation of a layered assembly
associated with the membrane structure revealed by cryo-TEM.
Since the SAXS prole for sol II also contains features associated
with a spherical micelle form factor, it was tted37 to a co-
existence of core–shell spherical micelle and Gaussian lipid
bilayer structures, the tting parameters being listed in Table
S1.† SAXS tting provided an outer micelle radius R1¼ 24.2 A˚, in
good agreement with the previously reported value27 and the
tting of the SAXS data for 2 wt% C16-KKFF (Fig. S1,†) indicates
a total bilayer thickness l ¼ (36  5) A˚, similar to the period d,
obtained from the Bragg peak position.
The Bragg peak for sol II is ascribed to a bilayer of C16-KKFF
with estimated length l of a hexadecyl chain (18 A˚) plus the
tetrapeptide in a b-sheet (4  3.4 A˚ ¼ 13.6 A˚). Since the
measured d and l values are more than one molecular length
but less than twice this value, it suggests interdigitation of the
molecules within the bilayer, as commonly observed for PA
assemblies.38–41 SEM data (to be discussed shortly) suggests that
the PA bilayer is preferentially sequestered at the surface of
a membrane wall with the NaAlg forming the bulk of the wall.
SAXS shows that there is a signicant population of spherical
micelles present in sol II as well as the planar membranes
evident in Fig. 1c. The addition of NaAlg into the PA solutionlginate into a PA solution. (a and b) Cryo-TEM images for sol I, showing
highlighted with black arrows) in (b), (c) cryo-TEM image for sol II, (d)
This journal is © The Royal Society of Chemistry 2017
Fig. 2 Images of sacs/capsules and SEM images. Photographs of (a) membrane sac in solution in a vial, (b) soft cap I, (c) self-supporting cap II.
SEM images of (d) membrane sac, (e) cap I and (f) cap II.
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View Article Onlineleads to a complex structuring process, a newmodel for which is
discussed below in the context of analysis of SEM images.
Having established that injection of NaAlg into the PA
solution leads to membrane structures based on bilayers of the
PA with NaAlg, we next investigated the production of
membrane sacs and so capsules in PA/NaAlg mixtures and
novel rigid capsules by incorporation of GO and/or CaCl2. Fig. 2
shows images of such structures. For example, by increasing the
concentration of NaAlg (and PA) used for sol II, it was possible
to prepare a membrane sac as illustrated in Fig. 2a (Table 1).
The membrane sac is highly exible and takes up the cationic
dye Rho B (an image from laser scanning confocal microscopy isFig. 3 Schematic of “Langmuir–Blodgett” deposition of PA layers
(shown as schematic surfactant-like molecules) onto injected NaAlg
(polymer shown as white coil). The size of the NaAlg polymer is not
shown in scale with that of the PA. The PA bilayer is 42 A˚ thick, the
NaAlg layer in the sacs formed by the membrane is tens of microns
thick. (a) The PA solution comprises a monolayer of molecules at the
air–water interface with micelles in equilibrium with a few unassoci-
ated molecules in solution, (b) the surface monolayer is adsorbed onto
the injected NaAlg in a Langmuir–Blodgett type process via electro-
static interaction between PA molecule headgroups and anionic
carboxyl groups in the NaAlg, (c) further PA molecules adsorb from
micelles and monomers in bulk, forming a multi-bilayer structure
coating the NaAlg.
This journal is © The Royal Society of Chemistry 2017provided in Fig. S2a†), as expected given that it comprises
a signicant fraction of anionic NaAlg polysaccharide.
We further show that it is possible to rationally increase the
stiﬀness of the PA/NaAlg membrane sac such that self-
supporting capsules are formed, by addition of GO and/or
CaCl2. Cap I, obtained by adding GO and increasing the PA
concentration in the membrane sac formulation, corresponds
to a so capsule that can be retrieved from water (Table 1 and
Fig. 2b). Cap I was further modied by adding CaCl2 and
increasing the GO concentration, to produce cap II which is
a rigid self-standing structure when retrieved from water (Table
1 and Fig. 2c).
The second row in Fig. 2 shows SEM images. The walls of
sacs produced from the membrane sac present three layers with
diﬀerent thickness and textures (Fig. 2d). The outer layers of the
membrane sac walls on each side are several tens of nanometres
thick, whereas the interior is several tens of microns thick (33.8
 7.6 mm thick in the case of the image in Fig. 2d), with a porous
hydrogel-like structure sandwiched between the external and
internal layers of the membrane. Fig. S2b† includes an enlarged
SEM image showing the structure of the interior part. We
ascribe the outer layers of membrane sac wall to PA bilayers
because the estimated outer layer thickness is very close to the
period obtained from the SAXS prole to be discussed shortly. It
has to be considered that the sample is prepared by injection of
the NaAlg solution into the PA solution. We suggest that this
occurs in the form of a “Langmuir–Blodgett deposition” type
event as the NaAlg membrane picks up amonolayer of PA (at the
air–water interface) as a coating (Fig. 3). This leads to a mono-
layer of PA at the surfaces of the membrane sac wall. The
exposed cationic residues from the peptide may be neutralized
preferentially on the surface facing the solution by the Na
counterions in solution enabling the (asymmetric) deposition ofRSC Adv., 2017, 7, 8366–8375 | 8371
Fig. 4 (a) SAXS and (b) WAXS data from the membrane sac, cap I and
cap II as indicated. The full line in (a) represents the ﬁtting to the SAXS
data. Parameters extracted from the SAXS ﬁtting in (a) are listed in
Table S3.† XRD spacings in (b) are listed in Table S4.†
Fig. 5 Biocompatibility testing after 24 hours of (a–d) membrane sacs
or (e–h) modiﬁed cap I ﬁlms. 24 hours after seeding, hASCs were
stained with calcein-AM (live indicator; green) and ethidium homo-
dimer-1 (dead indicator; red) before capturing images by ﬂuorescent
microscopy. (a and e) Bright ﬁeld, (b and f) ﬂuorescence and (c–d, g–h)
merged images; (d) and (h) are higher magniﬁcations of (c) and (g)
respectively.
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View Article Onlinefurther PA layers on one sac wall (ultimately the exterior sac
wall). The novel proposed “Langmuir–Blodgett” mechanism
shown in Fig. 3 for the structure of our membrane sac diﬀers
from the diﬀusional model proposed by Stupp et al. to account
for observed perpendicular PA bril growth at the surface of
polysaccharide sacs with their bril-forming PA system.17 Their
PA was designed to incorporate a b-sheet domain in the peptide
to drive bril formation. In contrast, C16-KKFF formsmicelles in
bulk but a population of layered structures in the presence of
NaAlg. Cap II formed in the presence of CaCl2 as a cross-linker
of NaAlg also has an ordered morphology in the capsule wall, as
conrmed directly by the SAXS proles below. For cap II,
mediation of PA interferes in the crosslinking of the injected
NaAlg by the Ca2+ ions in solution.
The Langmuir–Blodgett mechanism shown in Fig. 3 applies
to the case of injected NaAlg and will not apply in the case of
direct dissolution of PA into NaAlg solution as in the case of sol
I, where self-assembly occurs via non-interfacial interaction
between PA and NaAlg molecules leading to the formation of
bulk spherical micelles.
The SEM images for cap I and cap II (Fig. 2e and f) show
collapsed capsule-type structures consistent with the photo-
graphic images shown in Fig. 2b and c respectively. A cut across
the capsule wall shown in Fig. 2e and f exposes the capsule8372 | RSC Adv., 2017, 7, 8366–8375internal area. The capsule diameter is typically several hundred
mm. An enlarged SEM image showing the wall of cap I along
with an image of the interior structure of cap II are shown in
Fig. S3.†
SAXS and WAXS data for the membrane sac, cap I and cap II
are shown in Fig. 4. The SAXS data (Fig. 4a) shows a strong
Bragg reection which can be tted to a layered structure (Table
S3†), with a similar spacing to that of the weak, broad Bragg
peak for sol II discussed above. The Bragg peak for the
membrane sac is much stronger and sharper than for sol II,
indicating the presence of tens of repeats of the layer period.
This same peak is weaker for cap I and cap II, with a weaker
slope at low q arising from the bilayer form factor. The SAXS
peak position in Fig. 4a diﬀers from that measured for a NaAlg
control sample (Fig. S4 and Table S2†).
The SAXS features in Fig. 4a are also diﬀerent from those
measured for PA solutions with and without CaCl2, used to
prepare the samples in Fig. 4, which were tted using a spher-
ical shell form factor (Fig. S1 and Table S2†). The WAXS data for
the membrane sac and cap I show a peak at 4.4 A˚, tentatively
assigned to the b-strand spacing in a b-sheet structure (Table
S4†), although the value is somewhat lower than typically
observed (4.6–4.8 A˚). The membrane sac, cap I and cap II retain
features associated with NaAlg or/and GO, as shown by the
control WAXS experiments measured for the NaAlg and GO on
their own (Fig. S5 and Table S4†).
Together, the SAXS and WAXS data show that the structures
of membranes and capsules are both based on PA bilayers. In
addition, SAXS shows that the bilayer structure is intrinsic to
the membrane sac and capsules, as it is not found in the PA and
NaAlg sols used to produce the membrane sac, cap I or cap II. In
particular, in two separate experiments, cap I was stained with
solutions of the anionic dye Congo red or the cationic dye Rho
B. Similarly to the membrane sac shown in Fig. S2a,† cap I
absorbed Rho B (Fig. S6†), but did not absorb Congo red,
denoting a negatively charged capsule surface dominated by the
anionic NaAlg.This journal is © The Royal Society of Chemistry 2017
Fig. 6 Survival of S. aureus (red lines) and L. monocytogenes (black
lines) after exposure to the presence (membrane sac+) or absence
(NaAlg+) of the peptide under dry conditions. Estimations of the cell
numbers (CFU: colony-forming units) at each time point were per-
formed in triplicate (3 biological replicates) while each dilution was
plated in duplicate (2 technical replicates). Markers represent an
average of the measurements performed in triplicate, and error bars
represent the standard deviation. The dotted line represents the
detection limit of the method.
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View Article OnlineThe frequency dependence of the storage (G0) and loss (G00)
moduli measured for a membrane sac, cap I and cap II
(Fig. S7†), reveals a solid-like behaviour. During frequency
sweep experiments, the capsules are compressed by the shear
tool against the rheometer plate releasing the liquid entrapped
inside them; this liquid is then mixed by the shear tool with the
capsule walls, leading to a gel formation. As a consequence, G0
values measured for cap I and cap II are lower than those
measured for themembrane sac. However, G0 is higher for cap II
than for cap I, in agreement with the texture analysis results
shown in Fig. S8.† The observed values of the shear modulus
match those found in diﬀerent types of tissue.42
The cytocompatibility of the membrane sac was studied by
examining cell attachment and survival following seeding.
Human adipose-derived stem cells at high density were allowed
to attach to microscope coverslips coated with a membrane sac.
Aer 24 hours, a proportion of cells had attached to the
membrane (approximately 50%) and were relatively dispersed
across the surface. Cells maintained a rounded appearance and
exhibited a high incidence of cell death, with live/dead (calcein-
AM/ethidium homodimer-1) staining demonstrating 31  1%
viability (Fig. 5, top row). As an alternative, the cap I formulation
was modied to improve cytocompatibility by using a PA matrix
consisting of 1.5 wt% C16-KKFF + 0.5 wt% C16-G3RGD in 0.026
wt% CaCl2, instead of a pure PA matrix (Table 1). This formu-
lation provided a so capsule that was used to coat a micro-
scope coverslip. Whilst the number of cells attached was similar
to the membrane sac coating experiment, aer 24 hours cells
exhibited a less dispersed, more clustered appearance. Live/
dead cell staining revealed a better level of cell viability (72 
5%) demonstrating good cytocompatibility (Fig. 5, bottom row).
Live cells did persist aer 1 week of culture but they are only
seen oﬀ the sample with a line of red (dead) cells between the
glass and the gel (Fig. S9†) demonstrating toxicity over longerThis journal is © The Royal Society of Chemistry 2017terms in culture. Results from control experiments are shown in
Fig. S10.† Either calcium alginate or sodium alginate lms were
prepared from the same alginate sample. Cells persist on both
calcium alginate and sodium alginate aer 24 hours but exhibit
a clumped/rounded appearance similar to that seen on the
capsule. They do however maintain a high level of viability
suggesting that the presence of RGD is not necessary for
maintaining viability but that the reduction of content of the PA
C16-KKFF is the important factor.
Antimicrobial assays were performed against S. aureus, L.
monocytogenes, E. faecalis, P. aeruginosa and E. coli. The anti-
microbial activity of the peptide was similar under both dry and
liquid conditions. Out of the ve organisms tested, no eﬀect of
the peptide treatment was found against E. coli or P. aeruginosa
which both are Gram negative organisms (data not shown). The
logarithmic reduction in the number of colony-forming units
was similar both the presence and absence of the peptide,
during the course of the experiment. In contrast, an antimi-
crobial eﬀect of the peptide was found against the Gram posi-
tive microorganisms S. aureus (Fig. 6) and L. monocytogenes
(Fig. 6) and E. faecalis (Fig. S10†). A dramatic eﬀect was seen in
the case of L. monocytogenes, a signicant log reduction of more
than 6.30 orders of magnitude (counts were below the detection
limit on the 4th day) was measured in the presence of the
peptide, while in its absence a 1.20 log reduction occurred.
Similarly to S. aureus, the majority of the antimicrobial eﬀect
seemed to occur during the rst day.
To study the antimicrobial activity of the peptide we selected
both Gram negative and Gram positive microorganisms. One of
the Gram negative bacteria was E. coli, which is one of the most
studied microorganisms with a variety of pathogenic strains
causing conditions ranging from foodborne illness to urinary
infections.43 The other Gram negative bacterium was P. aerugi-
nosa that is the most common cause of nosocomial infections
aﬀecting the respiratory system (pneumonia) and the urinary
tract.44 Three Gram positive bacteria were also used of which
one was S. aureus, a highly important human pathogen
responsible for many nosocomial infections and deaths.34
Another bacterium tested was E. faecalis that is responsible for
many nosocomial infections45 (while the last one was L. mono-
cytogenes, currently the most deadly foodborne pathogen46
which can also aﬀect transplantation patients).47 The
membrane sac did not have any eﬀect on the Gram negative
bacteria E. coli and P. aeruginosa (data not shown), however it
had a moderate antibacterial eﬀect on S. aureus (Fig. 6) and E.
faecalis (Fig. S10†) and a signicant eﬀect on L. monocytogenes
(Fig. 6). These results clearly give an indication that the anti-
bacterial eﬀect might be specic to Gram positive bacteria. In
the case of L. monocytogenes we found a major antibacterial
eﬀect with the membrane sac eliminating completely all
measurable cells within 4 days (Fig. 6). This antimicrobial
activity pattern is comparable to that of the amphiphilic peptide
nisin48 that is active mainly against Gram positive bacteria such
as L. monocytogenes and S. aureus.49 Further work is required to
identify the antimicrobial activity of the peptide against other
organisms and establish the mode(s) of action. However, It is
well-known that the activity of antimicrobial peptides againstRSC Adv., 2017, 7, 8366–8375 | 8373
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View Article OnlineGram-positive bacteria is much larger than for Gram-negative
bacteria.50 It has been suggested that high hydrophobicity
may prevent peptide translocation through the outer membrane
of Gram negative bacteria. Therefore, it is not surprising that we
found an eﬀect against L. monocytogenes, E. faecalis and S.
aureus but no eﬀect against E. coli or P. aeruginosa suggesting
that the antimicrobial eﬀects are specically against Gram
positive organisms but not Gram negative ones.
4. Conclusions
We have created remarkable hybrid biomaterials based on the
co-operative self-assembly of the polysaccharide sodium algi-
nate with peptide amphiphiles. The mechanical properties of
sacs and capsules can be controlled through the injection
process (e.g. by addition of CaCl2 to modulate electrostatic
interactions) or via addition of graphene oxide, as a model
ultrathin planar inorganic nanostructure which is able to
modulate the rigidity of the capsules. These capsules represent
new hybrid organic/inorganic nanocomposites. A novel “Lang-
muir–Blodgett” mechanism for the interfacial formation of the
sac/capsule wall structures is presented, based on the aggrega-
tion of the cationic PA bilayers by electrostatic interaction with
the injected anionic alginate, starting from the PA solution
interface.
The capsules are cytocompatible and show highly selective
antimicrobial activity against an important human pathogen,
L. monocytogenes and to a lesser extend against S. aureus and E.
faecalis. The membranes have elasticity comparable to that of
human tissue (several kPa range) which may be useful in the
development of materials for stem cell diﬀerentiation
although the cytocompatibility may need to be improved, by
incorporation of more of cell adhesion motif (e.g. RGD) lip-
opeptides. In contrast to established Listeria antibacterial
agents such as essential oils,51 our capsules contain bioactive
lipopeptides which are embedded in the membrane-like
polymeric material which might be processed into a lm or
coating. These hybrid materials therefore have great potential
in the development of selective and highly active antibacterial
materials, addressing a major global healthcare challenge.
Another demonstrated application is in the selective uptake of
cationic molecules (here – dyes), pointing towards potential
applications in water treatment. Many other novel uses of
these materials are envisaged exploiting their unique struc-
tural and functional properties. For example, by reduction of
graphene oxide to graphene it may be possible to create
materials with interesting electronic properties, and the
encapsulation and barrier properties of the capsules are also
of great interest for future research.
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